Skip to Main Content
Table 1.

Health Panel members

Graham A. Colditz, Channing Laboratory, Boston, MA
Martin Jarvis, Health Behaviour Unit of Cancer Research UK, Department of Epidemiology and Public Health, University College London, London, United Kingdom 
Michael Kunze, Institute of Social Medicine, University of Vienna, Vienna, Austria 
Freddi Lewin, Department Oncology, Huddinge University Hospital, Stockholm, Sweden 
Jonathan M. Samet, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 
Peter Shields, Cancer Genetics and Epidemiology, Lombardi Cancer Center, Georgetown University Medical Center, Washington, DC 
Steven D. Stellman, Mailman School of Public Health, Department of Epidemiology, Columbia University, New York, NY 
Michael Thun, Department of Epidemiology and Surveillance, American Cancer Society, Atlanta, GA 
Deborah M. Winn, Epidemiology and Genetics Research Program, Division of Cancer Control and Population Sciences, NIH, Washington, DC 
Graham A. Colditz, Channing Laboratory, Boston, MA
Martin Jarvis, Health Behaviour Unit of Cancer Research UK, Department of Epidemiology and Public Health, University College London, London, United Kingdom 
Michael Kunze, Institute of Social Medicine, University of Vienna, Vienna, Austria 
Freddi Lewin, Department Oncology, Huddinge University Hospital, Stockholm, Sweden 
Jonathan M. Samet, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 
Peter Shields, Cancer Genetics and Epidemiology, Lombardi Cancer Center, Georgetown University Medical Center, Washington, DC 
Steven D. Stellman, Mailman School of Public Health, Department of Epidemiology, Columbia University, New York, NY 
Michael Thun, Department of Epidemiology and Surveillance, American Cancer Society, Atlanta, GA 
Deborah M. Winn, Epidemiology and Genetics Research Program, Division of Cancer Control and Population Sciences, NIH, Washington, DC 
Close Modal

or Create an Account

Close Modal
Close Modal